| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 01/08/2009 | US20090011497 Peptides and related compounds having thrombopoietic activity |
| 01/08/2009 | US20090011466 Concatameric immunoadhesion molecule |
| 01/08/2009 | US20090011465 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011461 Human Spasmolytic Polypeptide in Glycosylated Form |
| 01/08/2009 | US20090011460 Calcium-binding photoprotein, gene encoding the same, and use thereof |
| 01/08/2009 | US20090011453 Methods for Producing Proteins Using Hamster Igf-1 |
| 01/08/2009 | US20090011434 Methods And Compositions For Diagnosing Breast Cancer |
| 01/08/2009 | US20090011427 Assays for preimplantation factor and preimplantation factor peptides |
| 01/08/2009 | US20090011426 Methods of Diagnosis and Treatment of M.Tuberculosis Infection and Reagents Therefor |
| 01/08/2009 | US20090011113 Diacylglycerol acyltransferase nucleic acid sequences and associated products |
| 01/08/2009 | US20090011080 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090011000 Inhibitors of Infection |
| 01/08/2009 | US20090010996 Human antibiotic proteins |
| 01/08/2009 | US20090010988 Composition of bone formation with phsrn-rgd containing oligopeptide |
| 01/08/2009 | US20090010967 Clostridial toxin derivatives and methods for treating pain |
| 01/08/2009 | US20090010966 Modified diphtheria toxins |
| 01/08/2009 | US20090010961 Avirulent, immunogenic flavivirus chimeras |
| 01/08/2009 | US20090010960 Bacteriophage-mediated immunisation against hepatitis |
| 01/08/2009 | US20090010957 Immunogenic Mycoplasma Hyopneumoniae Polypeptides |
| 01/08/2009 | US20090010956 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 01/08/2009 | US20090010953 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010946 Novel Stromal Cell-Derived Factor-1 Polypeptides, Polynucleotides, Modulators Thereof and Methods of Use |
| 01/08/2009 | US20090010945 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group |
| 01/08/2009 | US20090010944 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | US20090010943 Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis |
| 01/08/2009 | US20090010942 Novel primate chitinases and uses therefor |
| 01/08/2009 | US20090010937 Membrane Attack Complexes Associated with Circulating Immune Complexes |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010935 Compositions and Methods of Treating Tumors |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010922 Compositions and methods for binding sphingosine-1-phosphate |
| 01/08/2009 | US20090010921 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
| 01/08/2009 | US20090010920 Fc Variants Having Decreased Affinity for FcyRIIb |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010879 Receptor Based Antagonists and Methods of Making and Using |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/08/2009 | US20090010874 Modified il-4 mutein receptor antagonists |
| 01/08/2009 | US20090010872 Chimeric soluble hyper il-11 and use thereof |
| 01/08/2009 | US20090010854 Pulmonary insulin crystals |
| 01/08/2009 | US20090010847 Connective Tissue Growth Factor-4 |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010839 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 01/08/2009 | DE102007031947A1 Allergene aus Aspergillus versicolor und Verfahren zum Nachweis einer innenraumbedingten Schimmelpilzallergie Allergens from Aspergillus versicolor and method for detecting an interior mold allergy-related |
| 01/08/2009 | CA2722015A1 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | CA2694282A1 Phage resistance |
| 01/08/2009 | CA2692603A1 Peptides facilitating retrograde transport and their uses |
| 01/08/2009 | CA2692509A1 Compounds and methods for the treatment of renal disease |
| 01/08/2009 | CA2691852A1 Methods and marker combinations for screening for predisposition to lung cancer |
| 01/08/2009 | CA2691825A1 Plasmid-encoded neurotoxin genes in clostridium botulinum serotype a subtypes |
| 01/08/2009 | CA2691699A1 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid .beta. peptide and its applications |
| 01/08/2009 | CA2691626A1 Pseudomonas aeruginosa-outer membrane protein pa4710 |
| 01/08/2009 | CA2691618A1 Mdl-1 uses |
| 01/08/2009 | CA2691378A1 Compositions and methods for treating and diagnosing cancer |
| 01/08/2009 | CA2691061A1 A cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 01/08/2009 | CA2690563A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/08/2009 | CA2690440A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | CA2690370A1 Modified globin proteins with altered electron transport pathway |
| 01/08/2009 | CA2687223A1 Diagnostic composition and method for the detection of a trichinella infection |
| 01/07/2009 | EP2012122A1 Mutated parvovirus structural proteins as vaccines |
| 01/07/2009 | EP2011888A1 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses |
| 01/07/2009 | EP2011880A1 Taurine transporter gene |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011876A1 Dna vaccine for koi herpes virus (khv) disease |
| 01/07/2009 | EP2011875A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011873A2 Tumor necrosis factor receptor-associated factors |
| 01/07/2009 | EP2011867A1 Pseudomonas aeruginosa outer membrane protein pa0427 |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP2011509A2 Pharmaceutical composition containing the nmb0606 protein |
| 01/07/2009 | EP2011503A2 High affinity nucleic acid ligands of cytokines |
| 01/07/2009 | EP2010910A2 Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
| 01/07/2009 | EP2010661A2 Proteins associated with abiotic stress response and homologs |
| 01/07/2009 | EP2010572A1 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 01/07/2009 | EP2010565A1 Method for recombinant protein production in cho cells |
| 01/07/2009 | EP2010564A2 The homeobox transcription factor bsx and uses thereof for treating diseases, in particular obesity |
| 01/07/2009 | EP2010563A1 Synthetic mecp2 sequence for protein substitution therapy |
| 01/07/2009 | EP2010562A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same |
| 01/07/2009 | EP2010561A1 Antimicrobial peptides |
| 01/07/2009 | EP2010560A2 Active potassium channel transporters (akt) and their use to create stress tolerant plants |
| 01/07/2009 | EP2010559A1 Production of compounds in a recombinant host |
| 01/07/2009 | EP2010558A1 Solubilization and purification of a target protein fused to a mutant maltose-binding protein |
| 01/07/2009 | EP2010557A2 High titer recombinant influenza viruses for vaccines |
| 01/07/2009 | EP2010556A2 Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation |
| 01/07/2009 | EP2010222A1 Pegylated factor viii |
| 01/07/2009 | EP2010209A2 Immunogenic wt-1 peptides and methods of use thereof |
| 01/07/2009 | EP2010207A2 Compositions and methods relating to modulation of immune system components |
| 01/07/2009 | EP2010201A1 Hcv vaccinations |
| 01/07/2009 | EP1902066A4 Il-6 binding proteins |
| 01/07/2009 | EP1740600A4 Intracellular delivery of osteoinductive proteins and peptides |
| 01/07/2009 | EP1711614B1 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 01/07/2009 | EP1709069B1 Epsilon-polylysine against halitosis |
| 01/07/2009 | EP1692165B1 High throughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein |
| 01/07/2009 | EP1689872B1 Promoters for expression in modified vaccinia virus ankara |
| 01/07/2009 | EP1624748A4 A transgenic animal model for cancer and stem cells |
| 01/07/2009 | EP1572893B1 Production of adeno-associated virus in insect cells |
| 01/07/2009 | EP1551868B1 Factor involved in metastasis and uses thereof |